Treatment Settings

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing the management of type 2 diabetes and obesity. Exciting new research suggests these medications may also hold immense promise for treating substance use...

In this first episode, Professor Goodman Sibeko sits down with Professor Nadine Harker to unpack what it really means for a workplace to take prevention seriously. Together, they explore how organisations can move beyond awareness campaigns...

Before exploring how workplaces can promote prevention and wellbeing, Professor Goodman Sibeko introduces Professor Nadine Harker, the voice and perspective behind much of this work. In this opening conversation, Professor Harker shares the...

ISSUP Argentina presents its webinar on Childhood, mothers with SUDs and protection systems.

Background Stigma related to drug use is a well-documented barrier to engaging and remaining on medication for opioid use disorder (MOUD), yet little is known about how stigma operates across multiple social and institutional settings in...

Background Smoking is more common in lower socioeconomic position (SEP) groups, but smoking cessation interventions are less effective for these groups. StopCoach, an mHealth intervention, supports people with lower SEP in quitting smoking...

Background The opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides...

Background and Objectives: Cognitive behavioral therapy (CBT) is the first-line treatment for gaming disorder (GD), as it addresses background factors. However, certain limitations exist. Cognitive training has been explored as an...

Drug abuse is increasingly concerning, requiring a rehabilitative approach through effective counselling by the Indonesian Government by strengthening drug prevention and eradication, because drug abuse in Indonesia is increasingly...